SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001144204-18-036682
Filing Date
2018-06-29
Accepted
2018-06-29 16:07:02
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tv497421_s3.htm S-3 160672
2 EXHIBIT 5.1 tv497421_ex5-1.htm EX-5.1 6389
3 EXHIBIT 10.4 tv497421_ex10-4.htm EX-10.4 6037
4 EXHIBIT 23.1 tv497421_ex23-1.htm EX-23.1 3712
  Complete submission text file 0001144204-18-036682.txt   178097
Mailing Address 1745 BROADWAY, 17TH FLOOR NEW YORK NY 10019
Business Address 1745 BROADWAY, 17TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-225995 | Film No.: 18929367
SIC: 2836 Biological Products, (No Diagnostic Substances)